 | • レポートコード：20QY06-01996 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ジェネリック医薬品のグローバル市場について種類別（シンプルジェネリック医薬品、スーパージェネリック医薬品、バイオシミラー）、用途別（CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リューマトロジー、糖尿病、腫瘍学、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ジェネリック医薬品市場の概要 ・世界の主要地域別ジェネリック医薬品市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のジェネリック医薬品市場規模2015-2026：種類別（シンプルジェネリック医薬品、スーパージェネリック医薬品、バイオシミラー） ・世界のジェネリック医薬品市場規模2015-2026：用途別（CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リューマトロジー、糖尿病、腫瘍学、その他） ・ジェネリック医薬品の北米市場規模2015-2020 ・ジェネリック医薬品のヨーロッパ市場規模2015-2020 ・ジェネリック医薬品の中国市場規模2015-2020 ・ジェネリック医薬品の日本市場規模2015-2020 ・ジェネリック医薬品の東南アジア市場規模2015-2020 ・ジェネリック医薬品のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Teva、Novartis - Sandoz、Mylan、Sun Pharmaceutical、Aspen、Fresenius Kabi、Pfizer (Hospira)、Sanofi、Aurobindo、Lupin、Dr. Reddy's、Apotex、Cipla、ENDO (Par Pharmaceutical)、Stada Arzneimittel、Krka Group、Nichi-Iko Pharmaceutical、Valeant、Zydus Cadila、Hikma） ・ジェネリック医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ジェネリック医薬品の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Generic Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Generic Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Generic Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Generic Drugs industry.
Based on our recent survey, we have several different scenarios about the Generic Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 257380 million in 2019. The market size of Generic Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Generic Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Generic Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Generic Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Generic Drugs market. The report also includes nautical information, where it shows Generic Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Generic Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Generic Drugs market.
The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
Geographical Analysis:
Based on region, the global Generic Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Generic Drugs market are
Teva
Novartis – Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy’s
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Segment by Type
Simple Generic Drugs
Super Generic Drugs
Biosimilars
Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Generic Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Generic Drugs market.
• The market share of the global Generic Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Generic Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Generic Drugs market.
1 Generic Drugs Market Overview
1.1 Generic Drugs Product Scope
1.2 Generic Drugs Segment by Type
1.2.1 Global Generic Drugs Sales by Type (2020-2026)
1.2.2 Simple Generic Drugs
1.2.3 Super Generic Drugs
1.2.4 Biosimilars
1.3 Generic Drugs Segment by Application
1.3.1 Global Generic Drugs Sales Comparison by Application (2020-2026)
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Generic Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Generic Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Generic Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Generic Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Generic Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Generic Drugs Industry
1.5.1.1 Generic Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Generic Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Generic Drugs Players to Combat Covid-19 Impact
2 Generic Drugs Estimate and Forecast by Region
2.1 Global Generic Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Generic Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Generic Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Generic Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Generic Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Generic Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Generic Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Generic Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Generic Drugs Estimates and Projections (2015-2026)
2.4.3 China Generic Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Generic Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Generic Drugs Estimates and Projections (2015-2026)
2.4.6 India Generic Drugs Estimates and Projections (2015-2026)
3 Global Generic Drugs Competition Landscape by Players
3.1 Global Top Generic Drugs Players by Sales (2015-2020)
3.2 Global Top Generic Drugs Players by Revenue (2015-2020)
3.3 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Drugs as of 2019)
3.4 Global Generic Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Generic Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Generic Drugs Players (Opinion Leaders)
4 Global Generic Drugs Market Size by Type
4.1 Global Generic Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Generic Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Generic Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Generic Drugs Price by Type (2014-2020)
4.2 Global Generic Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Generic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Generic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Generic Drugs Price Forecast by Type (2021-2026)
5 Global Generic Drugs Market Size by Application
5.1 Global Generic Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Generic Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Generic Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Generic Drugs Price by Application (2015-2020)
5.2 Global Generic Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Generic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Generic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Generic Drugs Price Forecast by Application (2021-2026)
3 North America Generic Drugs Market Facts & Figures
3.2 North America Generic Drugs Sales Market Share by Company (2015-2020)
3.3 North America Generic Drugs Sales Market Share by Type (2015-2020)
3.4 North America Generic Drugs Sales Market Share by Application (2015-2020)
4 Europe Generic Drugs Market Facts & Figures
4.2 Europe Generic Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Generic Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Generic Drugs Sales Market Share by Application (2015-2020)
5 China Generic Drugs Market Facts & Figures
5.2 China Generic Drugs Sales Market Share by Company (2015-2020)
5.3 China Generic Drugs Sales Market Share by Type (2015-2020)
5.4 China Generic Drugs Sales Market Share by Application (2015-2020)
6 Japan Generic Drugs Market Facts & Figures
6.2 Japan Generic Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Generic Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Generic Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Generic Drugs Market Facts & Figures
7.2 Southeast Asia Generic Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Generic Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Generic Drugs Sales Market Share by Application (2015-2020)
8 India Generic Drugs Market Facts & Figures
8.2 India Generic Drugs Sales Market Share by Company (2015-2020)
8.3 India Generic Drugs Sales Market Share by Type (2015-2020)
8.4 India Generic Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Generic Drugs Business
12.1 Teva
12.1.1 Teva Generic Drugs Corporation Information
12.1.2 Teva Generic Drugs Business Overview and Total Revenue
12.1.3 Teva Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Teva Generic Drugs Products Offered
12.1.5 Teva Recent Development
12.2 Novartis – Sandoz
12.2.1 Novartis – Sandoz Generic Drugs Corporation Information
12.2.2 Novartis – Sandoz Generic Drugs Business Overview and Total Revenue
12.2.3 Novartis – Sandoz Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis – Sandoz Generic Drugs Products Offered
12.2.5 Novartis – Sandoz Recent Development
12.3 Mylan
12.3.1 Mylan Generic Drugs Corporation Information
12.3.2 Mylan Generic Drugs Business Overview and Total Revenue
12.3.3 Mylan Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mylan Generic Drugs Products Offered
12.3.5 Mylan Recent Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Generic Drugs Corporation Information
12.4.2 Sun Pharmaceutical Generic Drugs Business Overview and Total Revenue
12.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sun Pharmaceutical Generic Drugs Products Offered
12.4.5 Sun Pharmaceutical Recent Development
12.5 Aspen
12.5.1 Aspen Generic Drugs Corporation Information
12.5.2 Aspen Generic Drugs Business Overview and Total Revenue
12.5.3 Aspen Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Aspen Generic Drugs Products Offered
12.5.5 Aspen Recent Development
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Generic Drugs Corporation Information
12.6.2 Fresenius Kabi Generic Drugs Business Overview and Total Revenue
12.6.3 Fresenius Kabi Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Fresenius Kabi Generic Drugs Products Offered
12.6.5 Fresenius Kabi Recent Development
12.7 Pfizer (Hospira)
12.7.1 Pfizer (Hospira) Generic Drugs Corporation Information
12.7.2 Pfizer (Hospira) Generic Drugs Business Overview and Total Revenue
12.7.3 Pfizer (Hospira) Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Pfizer (Hospira) Generic Drugs Products Offered
12.7.5 Pfizer (Hospira) Recent Development
12.8 Sanofi
12.8.1 Sanofi Generic Drugs Corporation Information
12.8.2 Sanofi Generic Drugs Business Overview and Total Revenue
12.8.3 Sanofi Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sanofi Generic Drugs Products Offered
12.8.5 Sanofi Recent Development
12.9 Aurobindo
12.9.1 Aurobindo Generic Drugs Corporation Information
12.9.2 Aurobindo Generic Drugs Business Overview and Total Revenue
12.9.3 Aurobindo Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Aurobindo Generic Drugs Products Offered
12.9.5 Aurobindo Recent Development
12.10 Lupin
12.10.1 Lupin Generic Drugs Corporation Information
12.10.2 Lupin Generic Drugs Business Overview and Total Revenue
12.10.3 Lupin Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Lupin Generic Drugs Products Offered
12.10.5 Lupin Recent Development
12.11 Dr. Reddy’s
12.11.1 Dr. Reddy’s Generic Drugs Corporation Information
12.11.2 Dr. Reddy’s Generic Drugs Business Overview and Total Revenue
12.11.3 Dr. Reddy’s Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Dr. Reddy’s Generic Drugs Products Offered
12.11.5 Dr. Reddy’s Recent Development
12.12 Apotex
12.12.1 Apotex Generic Drugs Corporation Information
12.12.2 Apotex Generic Drugs Business Overview and Total Revenue
12.12.3 Apotex Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Apotex Generic Drugs Products Offered
12.12.5 Apotex Recent Development
12.13 Cipla
12.13.1 Cipla Generic Drugs Corporation Information
12.13.2 Cipla Generic Drugs Business Overview and Total Revenue
12.13.3 Cipla Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Cipla Generic Drugs Products Offered
12.13.5 Cipla Recent Development
12.14 ENDO (Par Pharmaceutical)
12.14.1 ENDO (Par Pharmaceutical) Generic Drugs Corporation Information
12.14.2 ENDO (Par Pharmaceutical) Generic Drugs Business Overview and Total Revenue
12.14.3 ENDO (Par Pharmaceutical) Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 ENDO (Par Pharmaceutical) Generic Drugs Products Offered
12.14.5 ENDO (Par Pharmaceutical) Recent Development
12.15 Stada Arzneimittel
12.15.1 Stada Arzneimittel Generic Drugs Corporation Information
12.15.2 Stada Arzneimittel Generic Drugs Business Overview and Total Revenue
12.15.3 Stada Arzneimittel Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Stada Arzneimittel Generic Drugs Products Offered
12.15.5 Stada Arzneimittel Recent Development
12.16 Krka Group
12.16.1 Krka Group Generic Drugs Corporation Information
12.16.2 Krka Group Generic Drugs Business Overview and Total Revenue
12.16.3 Krka Group Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Krka Group Generic Drugs Products Offered
12.16.5 Krka Group Recent Development
12.17 Nichi-Iko Pharmaceutical
12.17.1 Nichi-Iko Pharmaceutical Generic Drugs Corporation Information
12.17.2 Nichi-Iko Pharmaceutical Generic Drugs Business Overview and Total Revenue
12.17.3 Nichi-Iko Pharmaceutical Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Nichi-Iko Pharmaceutical Generic Drugs Products Offered
12.17.5 Nichi-Iko Pharmaceutical Recent Development
12.18 Valeant
12.18.1 Valeant Generic Drugs Corporation Information
12.18.2 Valeant Generic Drugs Business Overview and Total Revenue
12.18.3 Valeant Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Valeant Generic Drugs Products Offered
12.18.5 Valeant Recent Development
12.19 Zydus Cadila
12.19.1 Zydus Cadila Generic Drugs Corporation Information
12.19.2 Zydus Cadila Generic Drugs Business Overview and Total Revenue
12.19.3 Zydus Cadila Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Zydus Cadila Generic Drugs Products Offered
12.19.5 Zydus Cadila Recent Development
12.20 Hikma
12.20.1 Hikma Generic Drugs Corporation Information
12.20.2 Hikma Generic Drugs Business Overview and Total Revenue
12.20.3 Hikma Generic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Hikma Generic Drugs Products Offered
12.20.5 Hikma Recent Development
13 Generic Drugs Manufacturing Cost Analysis
13.1 Generic Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Generic Drugs
13.4 Generic Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Generic Drugs Distributors List
14.3 Generic Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Generic Drugs Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Generic Drugs Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Generic Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Generic Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Generic Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Generic Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Generic Drugs Sales (K MT) by Region (2015-2020)
Table 10. Global Generic Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Generic Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Generic Drugs Revenue Share by Region (2015-2020)
Table 13. Global Generic Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Generic Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Generic Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Generic Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Generic Drugs (K MT) of Key Companies (2015-2020)
Table 18. Global Generic Drugs Sales Share by Company (2015-2020)
Table 19. Global Generic Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Generic Drugs Revenue Share by Company (2015-2020)
Table 21. Global Generic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Drugs as of 2019)
Table 22. Global Generic Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Generic Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Generic Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Generic Drugs Players
Table 27. Global Generic Drugs Sales (K MT) by Type (2015-2020)
Table 28. Global Generic Drugs Sales Share by Type (2015-2020)
Table 29. Global Generic Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Generic Drugs Price (K MT) by Type (2015-2020)
Table 31. Global Generic Drugs Sales Share by Type (2021-2026)
Table 32. Global Generic Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Generic Drugs Revenue Share by Type (2021-2026)
Table 34. Global Generic Drugs Price (K MT) by Type (2021-2026)
Table 35. Global Generic Drugs Sales (K MT) by Application (2015-2020)
Table 36. Global Generic Drugs Sales Share by Application (2015-2020)
Table 37. Global Generic Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Generic Drugs Price (K MT) by Application (2015-2020)
Table 39. Global Generic Drugs Sales (K MT) by Application (2021-2026)
Table 40. Global Generic Drugs Sales Share by Application (2021-2026)
Table 41. Global Generic Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Generic Drugs Revenue Share by Application (2021-2026)
Table 43. Global Generic Drugs Price (K MT) by Application (2021-2026)
Table 44. United States Generic Drugs Sales (K MT) by Company (2015-2020)
Table 45. United States Generic Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Generic Drugs Sales (K MT) by Type (2015-2020)
Table 47. United States Generic Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Generic Drugs Sales (K MT) by Application (2015-2020)
Table 49. United States Generic Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Generic Drugs Sales (K MT) by Company (2015-2020)
Table 51. Europe Generic Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Generic Drugs Sales (K MT) by Type (2015-2020)
Table 53. Europe Generic Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Generic Drugs Sales (K MT) by Application (2015-2020)
Table 55. Europe Generic Drugs Sales Market Share by Type (2015-2020)
Table 56. China Generic Drugs Sales (K MT) by Company (2015-2020)
Table 57. China Generic Drugs Sales Market Share by Company (2015-2020)
Table 58. China Generic Drugs Sales (K MT) by Type (2015-2020)
Table 59. China Generic Drugs Sales Market Share by Type (2015-2020)
Table 60. China Generic Drugs Sales (K MT) by Application (2015-2020)
Table 61. China Generic Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Generic Drugs Sales (K MT) by Company (2015-2020)
Table 63. Japan Generic Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Generic Drugs Sales (K MT) by Type (2015-2020)
Table 65. Japan Generic Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Generic Drugs Sales (K MT) by Application (2015-2020)
Table 67. Japan Generic Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Generic Drugs Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Generic Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Generic Drugs Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Generic Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Generic Drugs Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Generic Drugs Sales Market Share by Application (2015-2020)
Table 74. India Generic Drugs Sales (K MT) by Company (2015-2020)
Table 75. India Generic Drugs Sales Market Share by Company (2015-2020)
Table 76. India Generic Drugs Sales (K MT) by Type (2015-2020)
Table 77. India Generic Drugs Sales Market Share by Type (2015-2020)
Table 78. India Generic Drugs Sales (K MT) by Application (2015-2020)
Table 79. India Generic Drugs Sales Market Share by Application (2015-2020)
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Teva Generic Drugs Product
Table 84. Teva Recent Development
Table 85. Novartis - Sandoz Corporation Information
Table 86. Novartis - Sandoz Description and Business Overview
Table 87. Novartis - Sandoz Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Novartis - Sandoz Generic Drugs Product
Table 89. Novartis - Sandoz Recent Development
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Mylan Generic Drugs Product
Table 94. Mylan Recent Development
Table 95. Sun Pharmaceutical Corporation Information
Table 96. Sun Pharmaceutical Description and Business Overview
Table 97. Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Sun Pharmaceutical Generic Drugs Product
Table 99. Sun Pharmaceutical Recent Development
Table 100. Aspen Corporation Information
Table 101. Aspen Description and Business Overview
Table 102. Aspen Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Aspen Generic Drugs Product
Table 104. Aspen Recent Development
Table 105. Fresenius Kabi Corporation Information
Table 106. Fresenius Kabi Description and Business Overview
Table 107. Fresenius Kabi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Fresenius Kabi Generic Drugs Product
Table 109. Fresenius Kabi Recent Development
Table 110. Pfizer (Hospira) Corporation Information
Table 111. Pfizer (Hospira) Description and Business Overview
Table 112. Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Pfizer (Hospira) Generic Drugs Product
Table 114. Pfizer (Hospira) Recent Development
Table 115. Sanofi Corporation Information
Table 116. Sanofi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Sanofi Description and Business Overview
Table 118. Sanofi Generic Drugs Product
Table 119. Sanofi Recent Development
Table 120. Aurobindo Corporation Information
Table 121. Aurobindo Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Aurobindo Description and Business Overview
Table 123. Aurobindo Generic Drugs Product
Table 124. Aurobindo Recent Development
Table 125. Lupin Corporation Information
Table 126. Lupin Description and Business Overview
Table 127. Lupin Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Lupin Generic Drugs Product
Table 129. Lupin Recent Development
Table 130. Dr. Reddy's Corporation Information
Table 131. Dr. Reddy's Description and Business Overview
Table 132. Dr. Reddy's Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Dr. Reddy's Generic Drugs Product
Table 134. Dr. Reddy's Recent Development
Table 135. Apotex Corporation Information
Table 136. Apotex Description and Business Overview
Table 137. Apotex Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Apotex Generic Drugs Product
Table 139. Apotex Recent Development
Table 140. Cipla Corporation Information
Table 141. Cipla Description and Business Overview
Table 142. Cipla Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Cipla Generic Drugs Product
Table 144. Cipla Recent Development
Table 145. ENDO (Par Pharmaceutical) Corporation Information
Table 146. ENDO (Par Pharmaceutical) Description and Business Overview
Table 147. ENDO (Par Pharmaceutical) Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. ENDO (Par Pharmaceutical) Generic Drugs Product
Table 149. ENDO (Par Pharmaceutical) Recent Development
Table 150. Stada Arzneimittel Corporation Information
Table 151. Stada Arzneimittel Description and Business Overview
Table 152. Stada Arzneimittel Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Stada Arzneimittel Generic Drugs Product
Table 154. Stada Arzneimittel Recent Development
Table 155. Krka Group Corporation Information
Table 156. Krka Group Description and Business Overview
Table 157. Krka Group Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Krka Group Generic Drugs Product
Table 159. Krka Group Recent Development
Table 160. Nichi-Iko Pharmaceutical Corporation Information
Table 161. Nichi-Iko Pharmaceutical Description and Business Overview
Table 162. Nichi-Iko Pharmaceutical Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Nichi-Iko Pharmaceutical Generic Drugs Product
Table 164. Nichi-Iko Pharmaceutical Recent Development
Table 165. Valeant Corporation Information
Table 166. Valeant Description and Business Overview
Table 167. Valeant Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Valeant Generic Drugs Product
Table 169. Valeant Recent Development
Table 170. Zydus Cadila Corporation Information
Table 171. Zydus Cadila Description and Business Overview
Table 172. Zydus Cadila Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Zydus Cadila Generic Drugs Product
Table 174. Zydus Cadila Recent Development
Table . Hikma Corporation Information
Table . Hikma Description and Business Overview
Table . Hikma Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Hikma Generic Drugs Product
Table . Hikma Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Generic Drugs Distributors List
Table 183. Generic Drugs Customers List
Table 184. Market Key Trends
Table 185. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 186. Key Challenges
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Generic Drugs Product Picture
Figure 2. Global Generic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Generic Drugs Market Share by Application in 2020 & 2026
Figure 6. CNS Examples
Figure 7. Cardiovascular Examples
Figure 8. Genitourinary/Hormonal Drugs Examples
Figure 9. Respiratory Examples
Figure 10. Rheumatology Examples
Figure 11. Diabetes Examples
Figure 12. Oncology Examples
Figure 13. Others Examples
Figure 14. Global Generic Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 15. Global Generic Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 16. Global Generic Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 17. Global Generic Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 18. Global Generic Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 19. United States Generic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. United States Generic Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 21. Europe Generic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Europe Generic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. China Generic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. China Generic Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 25. Japan Generic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Japan Generic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Southeast Asia Generic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. Southeast Asia Generic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 29. India Generic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 30. India Generic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 31. Global 5 Largest Generic Drugs Players Market Share by Revenue in Generic Drugs 2015 & 2019
Figure 32. Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 33. Global Generic Drugs Revenue Share by Type (2015-2020)
Figure 34. Global Generic Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 35. Global Generic Drugs Revenue Share by Application (2015-2020)
Figure 36. Global Generic Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 37. United States Generic Drugs Sales Market Share by Type in 2019
Figure 38. United States Generic Drugs Sales Market Share by Type in 2019
Figure 39. Europe Generic Drugs Sales Market Share by Company in 2019
Figure 40. Europe Generic Drugs Sales Market Share by Type in 2019
Figure 41. Europe Generic Drugs Sales Market Share by Application in 2019
Figure 42. China Generic Drugs Sales Market Share by Company in 2019
Figure 43. China Generic Drugs Sales Market Share by Type in 2019
Figure 44. China Generic Drugs Sales Market Share by Application in 2019
Figure 45. Japan Generic Drugs Sales Market Share by Company in 2019
Figure 46. Japan Generic Drugs Sales Market Share by Type in 2019
Figure 47. Japan Generic Drugs Sales Market Share by Application in 2019
Figure 48. Southeast Asia Generic Drugs Sales Market Share by Company in 2019
Figure 49. Southeast Asia Generic Drugs Sales Market Share by Type in 2019
Figure 50. Southeast Asia Generic Drugs Sales Market Share by Application in 2019
Figure 51. India Generic Drugs Sales Market Share by Company in 2019
Figure 52. India Generic Drugs Sales Market Share by Type in 2019
Figure 53. India Generic Drugs Sales Market Share by Application in 2019
Figure 54. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Novartis - Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Aspen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Pfizer (Hospira) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Dr. Reddy's Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. ENDO (Par Pharmaceutical) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Stada Arzneimittel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Krka Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Nichi-Iko Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Key Raw Materials Price Trend
Figure 75. Manufacturing Cost Structure of Generic Drugs
Figure 76. Manufacturing Process Analysis of Generic Drugs
Figure 77. Generic Drugs Industrial Chain Analysis
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Porter's Five Forces Analysis
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
吸入＆点鼻薬ジェネリック医薬品の世界市場レポート2020 A recently published report by QY Research titled Global Inhalation & Nasal Spray Generic Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistical…- ジェネリック腫瘍滅菌注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Generic Oncology Sterile Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 12600 million by 2025, from USD 9912.3 million in 2019. The G…
- グラチラマー薬の世界市場レポート2020 A recently published report by QY Research titled Global Glatiramer Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate d…
- 泌尿生殖器薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Genitourinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genitourinary Drugs marke…
- 一般無菌注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Generic Sterile Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 63660 million by 2025, from USD 51320 million in 2019. The Generic Ste…